共 50 条
- [31] Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation Acta Pharmacologica Sinica, 2022, 43 : 2723 - 2734
- [34] Creatinine clearance and inappropriate dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation Heart and Vessels, 2020, 35 : 110 - 117
- [35] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172
- [37] Stroke Prophylaxis for Patients with non-valvular Atrial Fibrillation Rivaroxaban - effective also in multimorbid Patients MEDIZINISCHE WELT, 2017, 68 (06): : 268 - 269
- [38] Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years Heart and Vessels, 2019, 34 : 1858 - 1865